(24/7 MARKET NEWS) – Microbot Medical Inc. (NASDAQ: MBOT) announced, this morning, a highly successful extended joint pre- clinical animal study held at a leading European-based research lab.
Microbot Medical is trading at $1.58, up $0.350 (+28.46%), on 2.53M premarket shares traded.
Its 52-week range is $1.00 to $6.33. It’s bouncing off the 52-week low that it hit last week and looks ready to run.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
